Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY

OBJECTIVE: To compare the effectiveness of the BNT162b2 mRNA (Pfizer-BioNTech) and the ChAdOx1 (Oxford-AstraZeneca) covid-19 vaccines against infection and covid-19 disease in health and social care workers. DESIGN: Cohort study, emulating a comparative effectiveness trial, on behalf of NHS England....

Descripción completa

Detalles Bibliográficos
Autores principales: Hulme, William J, Williamson, Elizabeth J, Green, Amelia C A, Bhaskaran, Krishnan, McDonald, Helen I, Rentsch, Christopher T, Schultze, Anna, Tazare, John, Curtis, Helen J, Walker, Alex J, Tomlinson, Laurie A, Palmer, Tom, Horne, Elsie M F, MacKenna, Brian, Morton, Caroline E, Mehrkar, Amir, Morley, Jessica, Fisher, Louis, Bacon, Sebastian C J, Evans, David, Inglesby, Peter, Hickman, George, Davy, Simon, Ward, Tom, Croker, Richard, Eggo, Rosalind M, Wong, Angel Y S, Mathur, Rohini, Wing, Kevin, Forbes, Harriet, Grint, Daniel J, Douglas, Ian J, Evans, Stephen J W, Smeeth, Liam, Bates, Chris, Cockburn, Jonathan, Parry, John, Hester, Frank, Harper, Sam, Sterne, Jonathan A C, Hernán, Miguel A, Goldacre, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295078/
https://www.ncbi.nlm.nih.gov/pubmed/35858680
http://dx.doi.org/10.1136/bmj-2021-068946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295078/
https://www.ncbi.nlm.nih.gov/pubmed/35858680
http://dx.doi.org/10.1136/bmj-2021-068946

Ejemplares similares